Previous 10 | Next 10 |
2024-03-12 11:58:04 ET More on Applied DNA Sciences Applied DNA Sciences GAAP EPS of -$0.09 beats by $0.22, revenue of $0.89M beats by $0.11M Applied DNA announces $3.44M registered direct offering Read the full article on Seeking Alpha For further details se...
2024-02-09 13:32:06 ET Applied DNA Sciences, Inc. (APDN) Q1 2024 Results Conference Call February 08, 2024 04:30 PM ET Company Participants Sanjay Hurry - Head of IR Beth Jantzen - Chief Financial Officer Dr. James Hayward - Chairman, President and CEO Clay S...
2024-02-08 17:13:15 ET More on Applied DNA Sciences Applied DNA Sciences, Inc. (APDN) Q4 2023 Earnings Call Transcript Applied DNA announces $3.44M registered direct offering Seeking Alpha’s Quant Rating on Applied DNA Sciences Historical earnings data...
- Company On Track to Initiate First-Phase GMP Production Capacity for mRNA Critical Starting Materials During First Half of Calendar 2024, Projects Initial Facility Capacity to Enable up to $15 Million 1 of Linea IVT Revenue 2 Annually - - Conference Call/Webcast Scheduled for Today at 4:...
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...
STONY BROOK, NY / ACCESSWIRE / February 5, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its first quarter fiscal 2024 financial results after market close o...
STONY BROOK, NY / ACCESSWIRE / February 2, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that it has closed its previously announced registered direct offering of its common stock priced at-the-market under Nasdaq rules w...
2024-01-31 08:32:10 ET More on Applied DNA Sciences Applied DNA Sciences, Inc. (APDN) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Applied DNA Sciences Historical earnings data for Applied DNA Sciences Financial information for Appl...
STONY BROOK, NY / ACCESSWIRE / January 31, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that it has entered into securities purchase agreements (SPAs) with certain existing institutional investors (collectively the "Hold...
- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times - STONY BROOK, NY and NEEDHAM, MA / ACCESSWIRE / December 14, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Appli...
News, Short Squeeze, Breakout and More Instantly...
Applied DNA Sciences Inc. Company Name:
APDN Stock Symbol:
NASDAQ Market:
Applied DNA Sciences Inc. Website:
STONY BROOK, NY / ACCESSWIRE / July 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that the U.S. Defense Logistics Agency (DLA) exercised the first one-year option period of a three-year base contract with two one-year...
A look at the top 10 most actives in the United States Senti Biosciences Inc. (SNTI) rose 51.3% to $0.4175 on volume of 386,768,896 shares NVIDIA Corporation (NVDA) rose 0.6% to $124.3 on volume of 277,459,318 shares PROSHARES TRUST (SQQQ) fell 1.9% to $8.12 on volume of 139,088,335 share...
- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability - - Applied DNA Secures Commercial Linea RNAP Quantity Sufficient to Support Anticipated Near-Term Demand - STONY BROOK, NY AND JUPITER, FL / ACCES...